Simplex Trading
INBX icon

Simplex Trading’s Inhibrx INBX Stock Holding History

Simplex Trading’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,145
Closed -$84.9K – 9570
2025
Q4 		$90.5K Buy
+1,145
New +$78K ﹤0.01% 5094
2025
Q1 		– Sell
-1,147
Closed -$17K – 9015
2024
Q4 		$17K Sell
1,147
-1,003
-47% -$15.3K ﹤0.01% 6809
2024
Q3 		$33K Buy
+2,150
New +$30.2K ﹤0.01% 6264

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Simplex Trading's INBX Position: Q1 2026 in Review

Simplex Trading sold out of Inhibrx (INBX) in Q1 2026, closing a stake of 1,145 shares — an estimated $84.9K sold.

Simplex Trading first reported a position in INBX in Q3 2024 and held it in 3 quarters. The position peaked at $90.5K in Q4 2025. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Simplex Trading reported no remaining Inhibrx position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 1,145 Inhibrx shares in Q1 2026, an estimated $84.9K.
  • Simplex Trading first reported a position in Inhibrx in Q3 2024 and held it in 3 quarters.
  • Simplex Trading's Inhibrx position peaked at $90.5K in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.